Structure Therapeutics Surges 214% in One Year, Faces Institutional Reduction Cashing Out USD 15.52 Million

Life Science

Analysts See 3x Upside Potential, Overlooked Cancer Diagnostics Company Telix Could Be an Investment Dark Horse

Life Science

Patience Pays Off: Why These Two Healthcare Giants Are Worth the Wait

Life Science

Following Billionaire Laffont? Analyzing the Investment Thesis for Moderna

Life Science

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Life Science

Opportunity in the Sell-Off: 10 S&P 500 Stocks Down 20% That Analysts Are Bullish On

Financial Service, Life Science, Technology

What Will Drive Regeneron Pharmaceuticals in the Next Decade?

Life Science

Gilead to Acquire Arcellx for Up to $7.8 Billion, Doubling Down on Next-Generation CAR-T Therapy

Life Science

Aiming at a Billion-Dollar Market, Pfizer Doubles Down on Obesity Therapies in China

Life Science

Forget the S&P 500: Three Value ETFs Hitting New Highs Right Now

Consumer Goods, Financial Service, Life Science

This Weight-Loss Drug ‘Dark Horse’ Could Take You for a Ride

Life Science

Novo Nordisk Shares Plunge 16% as CagriSema Lags Behind Lilly’s Drug in Key Trial

Life Science

Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need

Life Science

Will One Comment from Eli Lilly Turn Around Novo Nordisk’s Stock?

Life Science

Is the Current US Stock Market Lacking Bargains? These Two High-Yield Dividend Stocks Are Worth Watching

Energy, Life Science